Jason Lettmann - Dec 2, 2024 Form 4 Insider Report for ALX ONCOLOGY HOLDINGS INC (ALXO)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Shelly Pinto, by power of attorney
Stock symbol
ALXO
Transactions as of
Dec 2, 2024
Transactions value $
$0
Form type
4
Date filed
12/4/2024, 04:13 PM
Previous filing
Aug 16, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALXO Employee Stock Option (right to buy) Award $0 +200K $0.00 200K Dec 2, 2024 Common Stock 200K $1.66 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares subject to the option vest in 30 equal monthly installments beginning on January 2, 2025.